PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
7.23%
Some net income increase while MRVL is negative at -94.74%. John Neff would see a short-term edge over the struggling competitor.
3.49%
Less D&A growth vs. MRVL's 159.02%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
675.00%
Some yoy growth while MRVL is negative at -2798.79%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
9.84%
Less SBC growth vs. MRVL's 149.00%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
139.52%
Slight usage while MRVL is negative at -51.72%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
109.01%
AR growth well above MRVL's 97.14%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-39.53%
Negative yoy inventory while MRVL is 56.19%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
61.19%
A yoy AP increase while MRVL is negative at -201.84%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
154.92%
Some yoy usage while MRVL is negative at -262.67%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-320.00%
Negative yoy while MRVL is 3798.88%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
62.24%
Some CFO growth while MRVL is negative at -51.90%. John Neff would note a short-term liquidity lead over the competitor.
-13.15%
Both yoy lines negative, with MRVL at -55.61%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-60.40%
Negative yoy purchasing while MRVL stands at 96.10%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-87.37%
We reduce yoy sales while MRVL is 150.93%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-1890.91%
We reduce yoy other investing while MRVL is 104.57%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-121.99%
Both yoy lines negative, with MRVL at -1015.29%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-3.31%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
25.09%
Buyback growth below 50% of MRVL's 8021.17%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.